Serum transforming growth factor-β levels depend on allergen exposure in allergic rhinitis

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background:Allergic rhinitis (AR) is characterized by inflammation sustained by dysregulated immune response. T-regulatory cells are involved in AR pathogenesis, mainly producing IL-10 and transforming growth factor (TGF)-β. Indeed, there is a functional and allergen-specific defect of T-regulatory cells in AR. However, there are no data about the influence of allergen exposure on TGF-β serum levels. Therefore, the aim of this preliminary study was to evaluate TGF-β serum levels in patients with seasonal AR. Patients were evaluated either outside the pollen season and after 1 preseasonal sublingual immunotherapy (SLIT) course (38 subjects) or during the pollen season (57 subjects). Methods:All patients were allergic to Parietaria and/or grasses alone. TGF-β was measured by a commercially available kit. Symptoms, drug use and eosinophils were evaluated.Serum allergen-specific IgG and IgA levels were also measured by the ELISA method. Results:TGF-β serum levels were significantly lower in patients evaluated outside the pollen season in comparison with the other 2 situations. SLIT induced the significantly highest TGF-β serum levels. There was a significant negative relationship between TGF-β and eosinophils in patients after SLIT. IgG and IgA levels were higher in SLIT-treated patients. Conclusion: This preliminary study provides evidence that TGF-β serum levels are significantly dependent on allergen exposure.

Original languageEnglish
Pages (from-to)66-70
Number of pages5
JournalInternational Archives of Allergy and Immunology
Volume152
Issue number1
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Transforming Growth Factors
Allergens
Sublingual Immunotherapy
Serum
Pollen
Regulatory T-Lymphocytes
Eosinophils
Immunoglobulin A
Parietaria
Immunoglobulin G
Seasonal Allergic Rhinitis
Allergic Rhinitis
Poaceae
Interleukin-10
Enzyme-Linked Immunosorbent Assay
Inflammation
Pharmaceutical Preparations

Keywords

  • Allergic rhinitis
  • Pollen season
  • Sublingual immunotherapy
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{c3812ad895634595ad858949c043e470,
title = "Serum transforming growth factor-β levels depend on allergen exposure in allergic rhinitis",
abstract = "Background:Allergic rhinitis (AR) is characterized by inflammation sustained by dysregulated immune response. T-regulatory cells are involved in AR pathogenesis, mainly producing IL-10 and transforming growth factor (TGF)-β. Indeed, there is a functional and allergen-specific defect of T-regulatory cells in AR. However, there are no data about the influence of allergen exposure on TGF-β serum levels. Therefore, the aim of this preliminary study was to evaluate TGF-β serum levels in patients with seasonal AR. Patients were evaluated either outside the pollen season and after 1 preseasonal sublingual immunotherapy (SLIT) course (38 subjects) or during the pollen season (57 subjects). Methods:All patients were allergic to Parietaria and/or grasses alone. TGF-β was measured by a commercially available kit. Symptoms, drug use and eosinophils were evaluated.Serum allergen-specific IgG and IgA levels were also measured by the ELISA method. Results:TGF-β serum levels were significantly lower in patients evaluated outside the pollen season in comparison with the other 2 situations. SLIT induced the significantly highest TGF-β serum levels. There was a significant negative relationship between TGF-β and eosinophils in patients after SLIT. IgG and IgA levels were higher in SLIT-treated patients. Conclusion: This preliminary study provides evidence that TGF-β serum levels are significantly dependent on allergen exposure.",
keywords = "Allergic rhinitis, Pollen season, Sublingual immunotherapy, Transforming growth factor-β",
author = "Giorgio Ciprandi and {De Amici}, Mara and Mariangela Tosca and Gianluigi Marseglia",
year = "2010",
month = "4",
doi = "10.1159/000260085",
language = "English",
volume = "152",
pages = "66--70",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Serum transforming growth factor-β levels depend on allergen exposure in allergic rhinitis

AU - Ciprandi, Giorgio

AU - De Amici, Mara

AU - Tosca, Mariangela

AU - Marseglia, Gianluigi

PY - 2010/4

Y1 - 2010/4

N2 - Background:Allergic rhinitis (AR) is characterized by inflammation sustained by dysregulated immune response. T-regulatory cells are involved in AR pathogenesis, mainly producing IL-10 and transforming growth factor (TGF)-β. Indeed, there is a functional and allergen-specific defect of T-regulatory cells in AR. However, there are no data about the influence of allergen exposure on TGF-β serum levels. Therefore, the aim of this preliminary study was to evaluate TGF-β serum levels in patients with seasonal AR. Patients were evaluated either outside the pollen season and after 1 preseasonal sublingual immunotherapy (SLIT) course (38 subjects) or during the pollen season (57 subjects). Methods:All patients were allergic to Parietaria and/or grasses alone. TGF-β was measured by a commercially available kit. Symptoms, drug use and eosinophils were evaluated.Serum allergen-specific IgG and IgA levels were also measured by the ELISA method. Results:TGF-β serum levels were significantly lower in patients evaluated outside the pollen season in comparison with the other 2 situations. SLIT induced the significantly highest TGF-β serum levels. There was a significant negative relationship between TGF-β and eosinophils in patients after SLIT. IgG and IgA levels were higher in SLIT-treated patients. Conclusion: This preliminary study provides evidence that TGF-β serum levels are significantly dependent on allergen exposure.

AB - Background:Allergic rhinitis (AR) is characterized by inflammation sustained by dysregulated immune response. T-regulatory cells are involved in AR pathogenesis, mainly producing IL-10 and transforming growth factor (TGF)-β. Indeed, there is a functional and allergen-specific defect of T-regulatory cells in AR. However, there are no data about the influence of allergen exposure on TGF-β serum levels. Therefore, the aim of this preliminary study was to evaluate TGF-β serum levels in patients with seasonal AR. Patients were evaluated either outside the pollen season and after 1 preseasonal sublingual immunotherapy (SLIT) course (38 subjects) or during the pollen season (57 subjects). Methods:All patients were allergic to Parietaria and/or grasses alone. TGF-β was measured by a commercially available kit. Symptoms, drug use and eosinophils were evaluated.Serum allergen-specific IgG and IgA levels were also measured by the ELISA method. Results:TGF-β serum levels were significantly lower in patients evaluated outside the pollen season in comparison with the other 2 situations. SLIT induced the significantly highest TGF-β serum levels. There was a significant negative relationship between TGF-β and eosinophils in patients after SLIT. IgG and IgA levels were higher in SLIT-treated patients. Conclusion: This preliminary study provides evidence that TGF-β serum levels are significantly dependent on allergen exposure.

KW - Allergic rhinitis

KW - Pollen season

KW - Sublingual immunotherapy

KW - Transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=70450191852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450191852&partnerID=8YFLogxK

U2 - 10.1159/000260085

DO - 10.1159/000260085

M3 - Article

VL - 152

SP - 66

EP - 70

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 1

ER -